EDIT
Editas Medicine, Inc.
NASDAQ · USHealthcareBiotechnology
$2.88-3.36%
Price as of Jul 20, 2026
EDIT valuation
Editas Medicine, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 26.23x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 63.97x
- Price / sales
- 7.29x
- Price / cash flow
- -2.01x
Enterprise value
- Enterprise value
- $230.3M
- EV / sales
- 5.95x
- EV / EBITDA
- -2.30x
- EV / EBIT
- -2.00x
- Market cap
- $282.0M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.